Quotation Notice
Budget at a Glance: A Panel Discussion on the Union and State Budgets – 2024
Nominations are invited for Annual Awards 2024
NANOMATERIALS INTERNATIONAL SYMPOSIUM (NIS)-2024
Heartian Guru Shreshta Awards 2023-2024 Recognize Excellence in Education
Globally, as of 29 November 2020, there have been 61,869,330 confirmed cases of COVID-19, including 1,448,896 deaths, reported to WHO.
COVID – 19 in India
Active – 446952
Deaths – 137139 (1.45%)
COVID – 19 in Kerala
Active – 64589
Deaths – 2223 (0.37%)
COVID-19 vaccine
Researchers worldwide are working around the clock to find a vaccine against SARS-CoV-2, the virus causing the COVID-19 pandemic. The Herculean effort means that a fast-tracked vaccine could come to market anywhere from the end of 2020 to the middle of 2021.
To date, just two coronavirus vaccine has been approved. Sputnik V – formerly known as Gam-COVID-Vac and developed by the Gamaleya Research Institute in Moscow – was approved by the Ministry of Health of the Russian Federation on 11 August. Experts have raised considerable concern about the vaccine’s safety and efficacy given it has not yet entered Phase 3 clinical trials. A second vaccine in Russia, EpiVacCorona, has also been granted regulatory approval, also without entering Phase 3 clinical trials.